Dr. Kwok-Kin Wong commented on the use of EZH2 inhibitors in lung cancer as needing more rationale in preclinical studies.
Dr. Atul Gawande is among Dana-Farber physicians and patients featured in Frontline’s new film, Being Mortal, which explores the relationships between doctors and patients at the end of life.
Dr. Philip Kantoff commented on therapeutic cancer vaccines.
Edward J. Benz, Jr. and Dr. Katherine Janeway commented on the benefit of
President Obama’s Precision Medicine Initiative that will benefit research at
Tags: Genomics, Genetics
WCVB-TV reporter and breast cancer survivor Kelley Tuthill is pregnant, and her oncologist, Dr. Ann Partridge, assured her studies show there is no link between pregnancy after successful treatment and recurrence.
Dana-Farber was mentioned in a story about how bureaucracy and outdated rules often block potential breakthroughs, but precision medicine is providing hope.
Tags: BasicResearch, Genomics, Genetics
Ludmila Svoboda, RN, was interviewed about her role as the program nurse in the Cancer Care Equity Program, which provides services for patients to help reduce disparities in cancer care.
Tags: PatientSupport, Disparities, CopingWithCancer
Dana-Farber was mentioned as one of the cancer centers taking samples of patient’s tumors to analyze with new molecular diagnostic tests and identify a mutation with the hope of matching it with an effective drug.
Dr. Ann LaCasce discussed how meditation has helped her do a better job of meeting her patients’ needs through an app called Headspace.
Rachel Freedman led a study, published in CANCER, that found many women
with breast cancer may lack knowledge regarding their illness.
Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02215 | Call us toll-free: